REVISIED LABELING FOR ADX BENZODIAZEPINES
K-Number: K880014 · 1988-02-11
Advertisement
Device Summary
Frequently Asked Questions
What is the REVISIED LABELING FOR ADX BENZODIAZEPINES?
REVISIED LABELING FOR ADX BENZODIAZEPINES is a medical device that received FDA 510(k) clearance on 1988-02-11. The listed applicant is Abbott Laboratories. The 510(k) number is K880014.
When did REVISIED LABELING FOR ADX BENZODIAZEPINES receive FDA 510(k) clearance?
REVISIED LABELING FOR ADX BENZODIAZEPINES received FDA 510(k) clearance on 1988-02-11, under 510(k) number K880014.
Who is the listed applicant for REVISIED LABELING FOR ADX BENZODIAZEPINES?
The FDA 510(k) record lists Abbott Laboratories as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for REVISIED LABELING FOR ADX BENZODIAZEPINES?
The FDA product code for REVISIED LABELING FOR ADX BENZODIAZEPINES is JXM.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Abbott Laboratories as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: JXM)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement